Cadila Healthcare informs about press release

01 Dec 2017 Evaluate

Cadila Healthcare has informed about press release titled ‘Zydus receives tentative approval from the USFDA for Pregabalin Capsules’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

889.00 -17.00 (-1.88%)
16-Mar-2026 16:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1778.00
Dr. Reddys Lab 1275.05
Cipla 1298.80
Zydus Lifesciences 889.00
Lupin 2286.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×